Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 18954362)

1.

Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.

Abu-Elmagd KM, Costa G, Bond GJ, Wu T, Murase N, Zeevi A, Simmons R, Soltys K, Sindhi R, Stein W, Demetris A, Mazariegos G.

Transpl Int. 2009 Jan;22(1):96-109. doi: 10.1111/j.1432-2277.2008.00785.x. Epub 2008 Oct 24. Review.

PMID:
18954362
2.

A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.

Abu-Elmagd KM, Costa G, Bond GJ, Soltys K, Martin L, Koritsky DA, Cunha-Melo JR, Sogawa H, Irish W, Tzakis A, Mazariegos G.

Clin Transpl. 2012:155-66.

PMID:
23721018
3.

Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.

Zanfi C, Lauro A, Cescon M, Dazzi A, Ercolani G, Grazi GL, Zanello M, Vivarelli M, Del Gaudio M, Ravaioli M, Cucchetti A, Vetrone G, Tuci F, Di Gioia P, Lazzarotto T, D'Errico A, Bagni A, Faenza S, Siniscalchi A, Pironi L, Pinna AD.

Transplant Proc. 2010 Jan-Feb;42(1):35-8. doi: 10.1016/j.transproceed.2009.12.019.

PMID:
20172276
4.

Evolutionary experience with immunosuppression in pediatric intestinal transplantation.

Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J.

J Pediatr Surg. 2005 Jan;40(1):274-9; discussion 279-80.

PMID:
15868597
5.

Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.

McCurry KR, Iacono A, Zeevi A, Yousem S, Girnita A, Husain S, Zaldonis D, Johnson B, Hattler BG, Starzl TE.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):528-37.

6.

Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period.

Lauro A, Amaduzzi A, Dazzi A, Ercolani G, Zanfi C, Golfieri L, Grazi GL, Vivarelli M, Cescon M, Varotti G, Del Gaudio M, Ravaioli M, Siniscalchi A, Faenza S, D'Errico A, Di Simone M, Pironi L, Pinna AD.

Dig Liver Dis. 2007 Mar;39(3):253-6. Epub 2007 Feb 1.

PMID:
17275428
7.

Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation.

Thomas PG, Woodside KJ, Lappin JA, Vaidya S, Rajaraman S, Gugliuzza KK.

Transplantation. 2007 Jun 15;83(11):1509-12.

PMID:
17565326
8.

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.

Marcos A, Eghtesad B, Fung JJ, Fontes P, Patel K, Devera M, Marsh W, Gayowski T, Demetris AJ, Gray EA, Flynn B, Zeevi A, Murase N, Starzl TE.

Transplantation. 2004 Oct 15;78(7):966-71.

9.

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.

Shapiro R, Basu A, Tan H, Gray E, Kahn A, Randhawa P, Murase N, Zeevi A, Girnita A, Metes D, Ness R, Bass DC, Demetris AJ, Fung JJ, Marcos A, Starzl TE.

J Am Coll Surg. 2005 Apr;200(4):505-15; quiz A59-61.

10.

Tolerogenic immunosuppression for organ transplantation.

Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, Corry RJ, Jordan ML, Fontes P, Gayowski T, Bond G, Scantlebury VP, Potdar S, Randhawa P, Wu T, Zeevi A, Nalesnik MA, Woodward J, Marcos A, Trucco M, Demetris AJ, Fung JJ.

Lancet. 2003 May 3;361(9368):1502-10.

11.

Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation.

Tan HP, Kaczorowski D, Basu A, McCauley J, Marcos A, Donaldson J, Unruh M, Randhawa P, Zeevi A, Shapiro R.

Transplant Proc. 2005 Dec;37(10):4235-40.

PMID:
16387087
12.

Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation.

Garcia M, Weppler D, Mittal N, Nishida S, Kato T, Tzakis A, Ruiz P.

Transplant Proc. 2004 Mar;36(2):323-4.

PMID:
15050146
13.

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffmann SC, Kampen RL, Cendales LK, Tadaki DK, Harlan DM, Swanson SJ.

Transplantation. 2003 Jul 15;76(1):120-9.

PMID:
12865797
14.

Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation.

Tzakis AG, Kato T, Nishida S, Levi DM, Madariaga JR, Nery JR, Mittal N, Regev A, Cantwell P, Gyamfi A, Weppler D, Miller J, Tryphonopoulos P, Ruiz P.

Transplantation. 2003 Apr 27;75(8):1227-31.

PMID:
12717207
15.

Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation.

Vianna RM, Mangus RS, Fridell JA, Weigman S, Kazimi M, Tector J.

Transplantation. 2008 May 15;85(9):1290-3. doi: 10.1097/TP.0b013e31816dd450.

PMID:
18475186
16.

The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.

Agarwal A, Shen LY, Kirk AD.

Transpl Immunol. 2008 Nov;20(1-2):6-11. doi: 10.1016/j.trim.2008.09.003. Epub 2008 Sep 29.

PMID:
18824230
17.

Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab.

Wu T, Bond G, Martin D, Nalesnik MA, Demetris AJ, Abu-Elmagd K.

Am J Gastroenterol. 2006 Jul;101(7):1617-24.

PMID:
16863569
18.

Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.

Lü TM, Yang SL, Wu WZ, Tan JM.

Chin Med J (Engl). 2011 Mar;124(5):664-8.

PMID:
21518554
19.

Clinical intestinal transplantation: a decade of experience at a single center.

Abu-Elmagd K, Reyes J, Bond G, Mazariegos G, Wu T, Murase N, Sindhi R, Martin D, Colangelo J, Zak M, Janson D, Ezzelarab M, Dvorchik I, Parizhskaya M, Deutsch M, Demetris A, Fung J, Starzl TE.

Ann Surg. 2001 Sep;234(3):404-16; discussion 416-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk